Dana Jung

770 total citations · 1 hit paper
9 papers, 462 citations indexed

About

Dana Jung is a scholar working on Molecular Biology, Immunology and Neurology. According to data from OpenAlex, Dana Jung has authored 9 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Neurology. Recurrent topics in Dana Jung's work include CAR-T cell therapy research (2 papers), Immune Cell Function and Interaction (2 papers) and RNA Research and Splicing (2 papers). Dana Jung is often cited by papers focused on CAR-T cell therapy research (2 papers), Immune Cell Function and Interaction (2 papers) and RNA Research and Splicing (2 papers). Dana Jung collaborates with scholars based in South Korea, United States and Pakistan. Dana Jung's co-authors include David Shin, Arnold R. Kriegstein, Alex A. Pollen, Madeline G. Andrews, Walter Mancia, Salma Jahan, Galina Schmunk, Denise E. Allen, Aparna Bhaduri and Maximilian Haeussler and has published in prestigious journals such as Nature, Cell Death and Disease and Cancers.

In The Last Decade

Dana Jung

9 papers receiving 452 citations

Hit Papers

Cell stress in cortical organoids impairs molecular subty... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Jung South Korea 6 323 86 85 49 43 9 462
Germán Belenguer Spain 10 206 0.6× 144 1.7× 33 0.4× 63 1.3× 45 1.0× 16 477
Kate M. Candelario United States 7 241 0.7× 74 0.9× 26 0.3× 37 0.8× 32 0.7× 10 370
Emily R. Lowry United States 9 294 0.9× 50 0.6× 51 0.6× 118 2.4× 40 0.9× 11 499
Lijie Guo China 10 271 0.8× 79 0.9× 133 1.6× 61 1.2× 44 1.0× 17 468
Mikkel A. Rasmussen Denmark 13 444 1.4× 66 0.8× 67 0.8× 101 2.1× 14 0.3× 34 560
Mari Maezawa Japan 5 263 0.8× 47 0.5× 243 2.9× 85 1.7× 123 2.9× 7 681
Nobuhiro Narii Japan 9 328 1.0× 115 1.3× 144 1.7× 103 2.1× 69 1.6× 19 512
Peng-Ming Zeng China 5 158 0.5× 44 0.5× 83 1.0× 48 1.0× 27 0.6× 9 276
Andreas Bruzelius Sweden 8 177 0.5× 50 0.6× 56 0.7× 80 1.6× 15 0.3× 14 311
Catherine Schwartz United States 11 400 1.2× 59 0.7× 43 0.5× 82 1.7× 17 0.4× 13 479

Countries citing papers authored by Dana Jung

Since Specialization
Citations

This map shows the geographic impact of Dana Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Jung more than expected).

Fields of papers citing papers by Dana Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Jung. The network helps show where Dana Jung may publish in the future.

Co-authorship network of co-authors of Dana Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Jung. A scholar is included among the top collaborators of Dana Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Jung. Dana Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jung, Dana, Eun‐Jeong Choi, Kyunghee Noh, et al.. (2025). Nanobody-Based CAR NK Cells for Possible Immunotherapy of Mesothelin+ Tumors. Immune Network. 25(3). e23–e23. 2 indexed citations
2.
Yoo, Wonbeak, Hyun‐Ji Choi, Dana Jung, et al.. (2025). Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer. Cancer Immunology Immunotherapy. 74(2). 73–73. 4 indexed citations
3.
Jung, Dana, et al.. (2024). Genomic analysis uncovers that cold-inducible RNA binding protein is associated with estrogen receptor in breast cancer. Genes & Genomics. 46(8). 899–907. 2 indexed citations
4.
Yoo, Wonbeak, Wonhwa Lee, Hong Nam Kim, et al.. (2022). Nanodiamond as a Cytokine Sponge in Infectious Diseases. Frontiers in Bioengineering and Biotechnology. 10. 862495–862495. 9 indexed citations
5.
Yoo, Wonbeak, Hyun‐Ji Choi, Dana Jung, et al.. (2022). Anti-Itching and Anti-Inflammatory Effects of Kushenol F via the Inhibition of TSLP Production. Pharmaceuticals. 15(11). 1347–1347. 5 indexed citations
6.
Yoo, Wonbeak, Hyun‐Ji Choi, Young Hoon Son, et al.. (2021). Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor. Experimental & Molecular Medicine. 53(3). 432–445. 14 indexed citations
7.
Bhaduri, Aparna, Madeline G. Andrews, Walter Mancia, et al.. (2020). Cell stress in cortical organoids impairs molecular subtype specification. Nature. 578(7793). 142–148. 357 indexed citations breakdown →
8.
Yoo, Wonbeak, Jaemin Lee, Kyung Hee Noh, et al.. (2019). Progranulin attenuates liver fibrosis by downregulating the inflammatory response. Cell Death and Disease. 10(10). 758–758. 45 indexed citations
9.
Yoo, Wonbeak, Eunsung Jun, Kyung Hee Noh, et al.. (2019). The YAP1–NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target. Cancers. 11(10). 1477–1477. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026